December 05, 2025 a 07:43 am
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc. demonstrates a robust market presence driven by its innovative solutions in the medical devices and cloud-based software domain. The company's comprehensive product portfolio in respiratory care positions it strategically in the healthcare sector. Investors may find the stock to have potential upside given its stable financial performance and industry standing.
Fundamental Rating
ResMed Inc. maintains a solid fundamental rating, reflecting its strengths in operational efficiency and market positioning.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Recent data showcases ResMed Inc.'s consistent scoring in key financial categories.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| 2025-12-04 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Current analyst price target projections suggest a promising range for ResMed Inc.'s stock value.
| High | Low | Median | Consensus |
|---|---|---|---|
| 305 | 280 | 299.5 | 296 |
Analyst Sentiment
Analyst sentiment indicates a favorable outlook for ResMed Inc. with a predominant 'Buy' consensus.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 12 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. stands out with strong fundamentals in the healthcare tech sector, providing reassurance to stakeholders about its growth potential. While the stock shows positives in analyst sentiments and projected price targets, investors should remain aware of wider industry risks. The company’s focus on innovative solutions could deliver sustained results. However, the moderate debt-to-equity ratio suggests a need for cautious financial management.